3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Colorectal Neoplasms
30
Rectal Neoplasms
7
Colonic Neoplasms
7
Carcinoma, Hepatocellular
7
Neoplasm Metastasis
5
Cholangiocarcinoma
5
Stomach Neoplasms
4
Neoplasms
3
Carcinoma, Non-Small-Cell Lung
3
Biliary Tract Neoplasms
3
Adenocarcinoma Of Esophagus
3
Ovarian Neoplasms
2
Gastrointestinal Neoplasms
2
Gallbladder Neoplasms
2
Esophageal Neoplasms
2
Solid Tumors
1
Recurrence
1
Pathologic Complete Response
1
Pancreatic Neoplasms
1
Neuroendocrine Tumors
1
Lung Neoplasms
1
Locally Advanced Rectal Cancer
1
Locally Advanced Colorectal Carcinoma
1
Liver Neoplasms
1
Gastroesophageal Junction Adenocarcinoma
1
Gastroesophageal Adenocarcinoma
1
Gastro-enteropancreatic neuroendocrine tumor
1
Endometrial Neoplasms
1
Disease Progression
1
Colorectal Cancer Metastatic
1
Interventions
enzalutamide
92
Magnetic Resonance Spectroscopy
87
Specimen Handling
66
Prednisone
65
Androgen Antagonists
59
Abiraterone Acetate
59
apalutamide
56
Radiosurgery
53
Radiotherapy
47
Leuprolide
47
darolutamide
46
abiraterone
44
Docetaxel
43
Radiation
31
Pluvicto
31
acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide
30
Biopsy
30
relugolix
28
Surveys and Questionnaires
28
pembrolizumab
26
gallium 68 PSMA-11
26
Standard of Care
26
Triptorelin Pamoate
25
Goserelin
25
bicalutamide
23
Gonadotropin-Releasing Hormone
23
Brachytherapy
21
Carboplatin
20
X-Rays
19
luprolide acetate gel depot
18
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Prostatic Neoplasms
×
Folfox protocol
×
1 year
×
Clear all
No trials found.